Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH
Por:
Batista, M, Perez-Garcia, J, Cussac, A, Cortez, P, Borrego, M, De la Haba, J, Cejalvo, J, Racca, F, Servitja, S, Blanch, S, Lema, L, Garmaje, M, Fernandez-Abad, M, Fernandez, A, Iranzo, V, Gonzalez-Santiago, S, Gion, M, Nave, M, Cortes, J and Braga, S
Publicada:
1 sep 2021
Ahead of Print:
1 sep 2021
Resumen:
Filiaciones:
Batista, M:
Hosp Prof Doutor Fernando Fonseca EPE, Med Oncol Dept, Lisbon, Portugal
Perez-Garcia, J:
Int Breast Canc Ctr IBCC, Med Oncol Dept, Quiron Grp, Barcelona, Spain
:
Hosp Arnau Vilanova, Med Oncol Dept, Valencia, Spain
Cortez, P:
Int Breast Canc Ctr IBCC, Med Oncol Dept, Quiron Grp, Barcelona, Spain
Borrego, M:
Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain
De la Haba, J:
Hosp Univ Reina SofIa, Oncol Dept, Cordoba, Spain
Cejalvo, J:
Univ Valencia, Hosp Clin, INCLIVA Inst Invest Sanit, Med Oncol Dept, Valencia, Spain
Racca, F:
IOB Inst Oncol, Med Oncol Dept, Quiron Grp, Barcelona, Spain
Servitja, S:
Hosp Mar, Med Oncol Dept, Barcelona, Spain
Blanch, S:
Fdn Inst Valenciano Oncol, Med Oncol Dept, Valencia, Spain
Lema, L:
Hosp 12 Octubre, Med Oncol Dept, Madrid, Spain
Garmaje, M:
Hosp Univ Son Llatzer, Med Oncol Dept, Palma De Mallorca, Spain
Fernandez-Abad, M:
Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
Fernandez, A:
Inst Catala Oncol, Med Oncol Dept, Barcelona, Spain
Iranzo, V:
Univ Valencia, Hosp Gen, Med Oncol, Valencia, Spain
Gonzalez-Santiago, S:
Hosp Univ San Pedro Alcantara, Med Oncol Dept, Caceres, Spain
Gion, M:
Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
Nave, M:
Hosp Luz, Med Oncol Dept, Lisbon, Portugal
Cortes, J:
VHIO Valle Hebron Inst Oncol, Oncol Dept, Barcelona, Spain
Braga, S:
Hosp Prof Doutor Fernando Fonseca EPE, Med Oncol Dept, Lisbon, Portugal
Bronze
|